inclusion criteria: 1. written informed consent, consistent with ich-gcp r2 and local laws, obtained before the initiation of any trial related procedure 2. diagnosis of coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test \< 4 days before visit 1 with signs of an acute respiratory infection 3. age \> 18 and \< 70 years 4. crp \> 50 and \< 150 mg/l 5. admitted to a hospital or controlled facility (home quarantine is not sufficient) 6. in the opinion of the investigator, the subject will be able to comply with the requirements of the protocol

inclusion criteria: 1. written informed consent, consistent with ich-gcp r2 and local laws, obtained before the initiation of any trial related procedure 2. diagnosis of coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test \< 4 days before visit 1 with signs of an acute respiratory infection 3. age \> 18 and \< 70 years 4. crp \> 50 and \< 150 mg/l 5. admitted to a hospital or controlled facility (home quarantine is not sufficient) 6. in the opinion of the investigator, the subject will be able to comply with the requirements of the protocol

inclusion criteria: written informed consent, consistent with ich-gcp r2 and local laws, obtained before the initiation of any trial related procedure diagnosis of coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test < 4 days before visit 1 with signs of an acute respiratory infection age > 18 and < 70 years crp > 50 and < 150 mg/l admitted to a hospital or controlled facility (home quarantine is not sufficient) in the opinion of the investigator, the subject will be able to comply with the requirements of the protocol

inclusion criteria: written informed consent, consistent with ich-gcp r2 and local laws, obtained before the initiation of any trial related procedure diagnosis of coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test < 4 days before visit 1 with signs of an acute respiratory infection age > 18 and < 70 years crp > 50 and < 150 mg/l admitted to a hospital or controlled facility (home quarantine is not sufficient) in the opinion of the investigator, the subject will be able to comply with the requirements of the protocol

inclusion criteria: 1. written informed consent, consistent with ich-gcp r2 and local laws, obtained before the initiation of any trial related procedure 2. diagnosis of coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test < 4 days before visit 1 with signs of an acute respiratory infection 3. age > 18 and < 70 years 4. crp > 50 and < 150 mg/l 5. admitted to a hospital or controlled facility (home quarantine is not sufficient) 6. in the opinion of the investigator, the subject will be able to comply with the requirements of the protocol

inclusion criteria: 1. written informed consent, consistent with ich-gcp r2 and local laws, obtained before the initiation of any trial related procedure 2. diagnosis of coronavirus (sars-cov)-2 infection confirmed by polymerase chain reaction (pcr) test < 4 days before visit 1 with signs of an acute respiratory infection 3. age > 18 and < 70 years 4. crp > 50 and < 150 mg/l 5. admitted to a hospital or controlled facility (home quarantine is not sufficient) 6. in the opinion of the investigator, the subject will be able to comply with the requirements of the protocol